Treatment of patients with atopic dermatitis with weekly dupilumab dosing: A single institutional retrospective medical record review and survey.

Competing Interests: Conflicts of interest Dr Rosmarin has received honoraria as a consultant for AbbVie, Boehringer-Ingelheim, Bristol Meyers Squibb, Celgene, Concert, Dermavant, Dermira, Incyte, Janssen, Kyowa Kirin, Lilly, Novartis, Pfizer, Regeneron, Sanofi, Sun Pharmaceuticals, UCB, and VielaBio. He has received research support from AbbVie, Amgen, Bristol Meyers Squibb, Celgene, Dermira, Galderma, Incyte, Janssen, Lilly, Merck, Novartis, Pfizer, and Regeneron Pharmaceuticals Inc. He has also served as a paid speaker for AbbVie, Amgen, Celgene, Janssen, Lilly, Novartis, Pfizer, Regeneron Pharmaceuticals Inc, and Sanofi. Authors Gao, Kahn, and Dumont and Drs Cohen, Fiumara, and Lam have no conflicts of interest to declare.